Limited Edition Golden Llama is here! Check out how you can get one. Limited Edition Golden Llama is here! Check out how you can get one.
Offering SPR-BLI Services - Proteins provided for free! Get your ComboX free sample to test now!
Time Limited Offer: Welcome Gift for New Customers ! Shipping Price Reduction for EU Regions
>
Protéines du récepteur Fc
L'efficacité d'un anticorps thérapeutique dépend non seulement du fragment Fab et de son activité de liaison à l'antigène cible, mais également du fragment Fc et de son interaction avec les récepteurs Fc clés. L'affinité de liaison du fragment Fc au FcRn (FCGRT&B2M) prévoirait la demi-vie de l'anticorps, tandis que celle entre le fragment Fc et le FcγRIIIa (CD16a) influencerait la capacité de l'anticorps à obtiendrait un ADCC (anticorps dépendant de la cytotoxicité à médiation cellulaire). Par conséquent, les candidats doivent être testés contre un panel de récepteurs lors de l'ingénierie des anticorps.
ACROBiosystems propose une collection complète de produits de récepteurs Fc, y compris FcRn. FcγRs et leurs variantes courantes, pour accélérer le développement de vos anticorps monoclonaux.
Nouvelle recommandation de produit: Kit de liaison FcRn humain (TR-FRET), Human Fc gamma RI / CD64 Binding Kit(TR-FRET)
Il est facile à utiliser, très sensible et les résultats sont précis, ce qui permet de soutenir et d'accélérer le processus de recherche et de développement des médicaments à base d'anticorps.
Cellules exprimées par HEK293 : modification post-translationnelle et repliement correct des protéines
Espèces multiples : Humain, Souris, Cynomolgus/Rhésus macaque, Rat, Porcin, Lapin, Félin, Bovin, peuvent être entièrement appliquées à différentes expériences sur espèces croisées
Haute pureté : Vérification de la pureté SDS-PAGE >95%, vérification de la pureté SEC-MALS >90%
Faible endotoxine : <1.0 EU/µg
Haute stabilité :contrôle de qualité strict pour assurer une haute cohérence de lot à lot
Protéines du récepteur Fc biotinylées marquées avec AvitagTM offertes : l'efficacité de marquage est élevée, et le site de marquage est spécifique et clair, ce qui convient à la détection ELISA/RPS/BLI basée sur la liaison à la streptavidine dans le processus de développement et d'optimisation des médicaments
Affinité vérifiée par SPR et BLI : activité garantie, et protocoles offerts gratuitement
To meet the high purity requirement of pharmaceutical applications, our production team perform both SDS-PAGE and SEC-MALS analyses to the Fc receptors for QC purposes. It’s noteworthy that it’s essential to use monomeric Fc receptor, which represents its natural state. The formation of oligomers during production may result in artificially enhanced binding interaction due to avidity effect. To avoid such situation, we have established strict internal control standards of monomer purity by SEC-MALS testing. Only those batches meeting all purity requirements are released.
Fig. 1 The purity of Human CD32a (R167), His Tag (Cat. No. CDA-H5221) is more than 95% verified by SDS-PAGE. The purity of Human CD32a (R167), His Tag (Cat. No. CDA-H5221) is more than 90% verified by SEC-MALS. And the molecular weight of this protein is around 25-35 kDa.
The binding affinity between two molecules can be determined by many methods. However, the studies of Fc interaction are often done by SPR, because traditional ELISA is not appropriate for low affinity receptors such as CD16 and CD32. To assure our Fc receptors deliver expected performance, our QC team use Biacore platform to test our products against reference antibodies. Additionally, to meet more applications in the development of antibody drugs, our QC team also use ForteBio platform to test our products against reference antibodies. All SPR&BLI protocols are available for free.
Fig. 2 Human CD64, His Tag (SPR & BLI verified) (Cat. No. FCA-H52H1) captured on CM5 chip via anti-His antibody can bind Herc*ptin with an affinity constant of 4.92 nM as determined in a SPR assay (Biacore 8K) (QC tested).
Fig. 3 Immobilized Human FCGRT&B2M Heterodimer Protein, His Tag&Strep II Tag (SPR & BLI verified) (Cat. No. FCM-H5286) on CM5 Chip via Anti-His antibody, can bind Herc*ptin with an affinity constant of 0.261 μM as determined in a SPR assay (Biacore T200).
Fig. 4 Loaded Human CD64, His Tag (SPR & BLI verified) (Cat. No. FCA-H52H1) on HIS1K Biosensor, can bind Herc*ptin with an affinity constant of 6.98 nM as determined in BLI assay (ForteBio Octet Red96e).
Fig. 5 Loaded Human FCGRT&B2M Heterodimer Protein, His Tag (SPR & BLI verified) (Cat. No. FCN-H52W7) on SA Biosensor via Biotin his antibody, can bind Herc*ptin with an affinity constant of 0.14 μM as determined in BLI assay (ForteBio Octet Red96e).
We routinely apply rigorous quality control measures to ensure consistent performance of our product. As shown below, the batch variation among the tested samples is negligible.
Fig. 6 Immobilized Human Fc gamma RIIB / CD32b Protein (Cat. No. CDB-H5228) on CM5 Chip via anti-His antibody, can bind Ritux*mab with an affinity constant of 10 μM as determined in a SPR assay (Biacore T200).
We have compared the performance of different batches of CD32b (CDB-H5228) in the same assay, and the software analysis showed that the similarity score was very high, meaning high batch-to-batch consistency.
Fig. 7 Batch consistency of Human Fc gamma RIIB / CD32b (Cat. No. CDB-H5228). The consistency of different batches is more than 90%.
The use of biotin labeling can make your assay development much easier. We offer a variety of ready-to-use biotinylated Fc receptors. These proteins are produced using our in-house developed labeling techniques, which confers high bioactivity and minimal batch-to-batch variation. In addition, we have developed a series of Fc receptors of other species, which are suitable for the screening of non-humanized antibodies or the species cross reaction.
Fig. 8 Biotinylated Human CD16a (V176), His Tag, Avi Tag (Cat. No.CDA-H82E9) captured on Biotin CAP- Series S Sensor Chip can bind Ritux*mab with an affinity constant of 0.261 μM as determined in a SPR assay (Biacore T200).
Fig. 9 Immobilized Cynomolgus / Rhesus macaque FcRn Protein (Cat. No. FCM-C5284) on CM5 Chip via anti-His antibody, can bind Herc*ptin with an affinity constant of 0.403 μM as determined in a SPR assay (Biacore T200).
FcRn
FcγR
FcεR
Molécule | Cat. N° | Hôte | Description du Produit | Structure |
---|
Molécule | Cat. N° | Hôte | Description du Produit | Structure |
---|
Molécule | Cat. N° | Hôte | Description du Produit | Structure |
---|
Authors: Kielau Kisalu, Neville et al.
Journal: JCI Insight 2020
Cited Product: FCM-H5286,FCM-C5284,FCM-M82W5
Application: BLI
Authors: Asokan M, Dias J, Liu C, et al
Cited Product: FCM-C5284
Journal: Proc Natl Acad Sci U S A2020
Application: BLI
Authors: Simonov V, et al
Cited Product: FCM-H5286
Journal: Biologicals 2019
Application: BLI
Engineered antibody Fc variants for enhanced serum half life
Authors: G Georgiou, et al
Cited Product: FCM-H5286
Journal: US20190048078A1 2019
Application: SPR
Authors: Yang B, et al.
Cited Product: FCM-H5286,FCM-M52W2
Journal: Biomater Sci 2018
Application: ELISA
Authors: Zhao C, et al.
Cited Product: FCM-H5286
Journal: Mol Cell Endocrinol 2018
Application: SPR
Authors: Kenniston JA, et al.
Cited Product: FCM-H5286,FCM-M52W2,FCM-R5287,FCM-C5284
Journal: J Biol Chem 2017
Application: ELISA & SPR
Single chain Fc-dimer-human growth hormone fusion protein for improved drug delivery
Authors: Li Zhou, et al.
Cited Product: FCM-H5286
Journal: Biomaterials 2016
Application: SPR
CD38 ecto-enzyme in immune cells is induced during aging and regulates NAD + and N*N levels
Authors: Chini CCS, Peclat TR, Warner GM, et al.
Cited Product: FC4-M52H3,CD4-M5227
Journal: Nature metabolism 2020
Application: Binding Assay
Authors: Simonov V, et al
Cited Product: CDB-H5228,CDA-H5221,CDA-H5220,CDB-H5222
Journal: Biologicals 2019
Application: SPR
Identification of anti-CD16a single domain antibodies and their application in bispecific antibodies
Authors: Zhao Y, et al
Cited Product: CDA-H5220
Journal: Cancer Biol Ther 2019
Application: immunization
Charge variant analysis of proposed biosimilar to Trastuz*mab
Authors: Dakshinamurthy P, et al.
Cited Product: CD8-H52H4
Journal: Biologicals 2017
Application: SPR
Sialylation of immunoglobulin E is a determinant of allergic pathogenicity
Authors: Kai Ting C Shade, et al
Cited Product: CD3-H5249
Journal: Nature 2020
Application: BLI
This web search service is supported by Google Inc.